Home / Ifosfamide / Belgium
BE ATC L01AA06 · updated 2 Nov 2026
Ifosfamide shortage in Belgium
Is there an Ifosfamide shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Ifosfamide product is reported short in Belgium, the first since 28 Jan 2026. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in United States, Germany, France, Italy, Austria, Switzerland, Czechia, Norway, Sweden, Japan, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Holoxan 1 g inj. sol. (pwdr.) i.v. vial 10 x 1000 mg limited | Baxter | 28 Jan 2026 | 31 Dec 2026 | Manufacturing problem Delay in the release of the end product |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.